To study effect of therapy on tumour response
Not Applicable
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2020/05/025307
- Lead Sponsor
- Rasayu Cancer Clinic Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1 Biopsy or Histopathologically confirmed any stage Cancer
2 Have taken more than 6 months of Rasayana therapy and Completed chemotherapy treatment simultaneously
Exclusion Criteria
1. Diagnosed cases of carcinoma of stage I and II
2. Those patients who are not ready for the study.
3. Patients taking Radiotherapy.
4. Patients have taken less than 6 months of Rasayana Therapy
5. Patients with an expected survival of less than 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the incidence of tumor response in cancer patients receiving Ayurveda Rasayana therapy along with chemotherapy <br/ ><br>Timepoint: 6 to 12 months
- Secondary Outcome Measures
Name Time Method 1 To assess QOL of patients Receiving Ayurveda Rasayana therapy along with chemotherapy <br/ ><br>2 To assess incidence of adverse drug reactions using CTCAE V 5 criteria of chemotherapy along with Rasayana therapy <br/ ><br>3 To assess safety and tolerability to both treatment simultaneously <br/ ><br>4 Real world evidence to see its antagonistic/synergistic effect <br/ ><br>5 To establish scientific based clarity to patients <br/ ><br>Timepoint: 6 to 12 months